Curcumin-incorporated albumin nanoparticles and its tumor image

Nanotechnology

Volumn 26, Issue 4, 2015, Pages

  Gong, Guangming ^a   Pan, Qinqin ^b   Wang, Kaikai ^c   Wu, Rongchun ^a   Sun, Yong ^d   Lu, Ying ^d  

^a Department of Research and Development Nanjing Kaisirui Biotechnology ^*  (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Albumin; Curcumin; Nanoparticles; Self assembly

Indexed keywords

CHEMOTHERAPY; COVALENT BONDS; CYTOLOGY; HYDROPHOBICITY; QUENCHING; SELF ASSEMBLY; TUMORS;

ALBUMIN; ALBUMIN NANOPARTICLES; CONFORMATIONAL CHANGE; CURCUMIN; FLUORESCENCE QUENCHING; HSA NANOPARTICLES; HUMAN SERUM ALBUMINS; HYDROPHOBIC INTERACTIONS;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; CURCUMIN; DRUG CARRIER; MERCAPTOETHANOL; NANOPARTICLE; SERUM ALBUMIN;

ANALOGS AND DERIVATIVES; ANIMAL; BREAST NEOPLASMS; CHEMICAL PHENOMENA; CHEMISTRY; DIAGNOSTIC USE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MCF 7 CELL LINE; PARTICLE SIZE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CURCUMIN; DRUG CARRIERS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MCF-7 CELLS; MERCAPTOETHANOL; MICE, INBRED ICR; NANOPARTICLES; PARTICLE SIZE; SERUM ALBUMIN;

EID: 84920861042     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/26/4/045603     Document Type: Article

References (41)

1. Anderson A M, Mitchell M S and Mohan R S 2000 Isolation of CCM from turmeric J. Chem. Educ. 77 359-60
2. Pizzo P, Scapin C, Vitadello M, Florean C and Gorza L 2010 Grp94 acts as a mediator of CCM-induced antioxidant defence in myogenic cells J. Cell. Mol. Med. 14 970-81
3. Aggarwal B B and Harikumar K B 2009 Potential therapeutic effects of CCM, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J. Biochem. Cell Biol. 41 40-59
4. Lee Y K, Lee W S, Hwang J T, Kwon D Y, Surh Y J and Park O J 2009 CCM exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells J. Agric. Food. Chem. 57 305-10
5. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair G B and Mukhopadhyay A K 2009 Antimicrobial activity of CCM against helicobacter pylori isolates from India and during infections in mice Antimicrob. Agents. Chemother. 53 1592-7
6. Wang Y, Lu Z, Wu H and Lv F 2009 Study on the antibiotic activity of microcapsule CCM against foodborne pathogens Int. J. Food. Microbiol. 136 71-4
7. Dhillon N, Aggarwal B B, Newman R A, Wolff R A, Kunnumakkara A B, Abbruzzese J L, Ng C S, Badmaev V and Kurzrock R 2008 Phase II trial of CCM in patients with advanced pancreatic cancer Clin. Cancer Res. 14 4491-9
8. Parvathy K S, Negi P S and Srinivas P 2010 CCMeamino acid conjugates: synthesis, antioxidant and antimutagenic attributes Food. Chem. 120 523-30
9. Manju S and Sreenivasan K 2011 Conjugation of CCM onto hyaluronic acid enhances its aqueous solubility and stability J. Colloid Interface Sci. 359 318-25
10. Tang H, Murphy C J, Zhang B, Shen Y, Sui M, Van Kirk E A, Feng X and Murdoch W J 2010 Amphiphilic CCM conjugate-forming NPs as anticancer prodrug and drug carriers: in vitro and in vivo effects Nanomedicine (Lond) 5 855-65
11. Saengkrit N, Saesoo S, Srinuanchai W, Phunpee S and Ruktanonchai U R 2014 Influence of CCM-loaded cationic liposome on anticancer activity for cervical cancer therapy Colloids Surf. B 114 349-56
12. Karewicz A, Bielska D, Loboda A, Gzyl-Malcher B, Bednar J, Jozkowicz A, Dulak J and Nowakowska M 2013 CCMcontaining liposomes stabilized by thin layers of chitosan derivatives Colloids Surf. B 109 307-16
13. Shaikh J, Ankola D D, Beniwal V, Singh D and Kumar M N 2009 Nanoparticle encapsulation improves oral bioavailability of CCM by at least 9-fold when compared to CCM administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 37 223-30
14. Yallapu M M, Gupta B K, Jaggi M and Chauhan S C 2010 Fabrication of CCM encapsulated PLGA NPs for improved therapeutic effects in metastatic cancer cells J. Colloid Interface Sci. 351 19-29
15. Liu J, Xu L, Liu C, Zhang D, Wang S, Deng Z, Lou W, Xu H, Bai Q and Ma J 2012 Preparation and characterization of cationic HSA-CCM NPs for improvement of cellular uptake Carbohydr. Polym. 90 16-22
16. Anitha A, Deepagan V G, Divya Rani V V, Menon D, Nair S V and Jayakumar R 2011 Preparation, characterization, in vitro drug release and biological studies of CCM loaded dextran sulphate-chitosan NPs Carbohyd. Polym. 84 1158-64
17. Song L, Shen Y Y, Hou J W, Lei L, Guo S R and Qian C Y 2011 Polymeric micelles for parenteral delivery of CCM: preparation, characterization and in vitro evaluation Colloids Surf. A 390 25-32
18. Song Z, Feng R, Sun M, Guo C, Gao Y, Li L and Zhai G 2011 CCM-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo J. Colloid Interface Sci. 354 116-23
19. Gupta V, Aseh A, Rios C N, Aggarwal B B and Mathur A B 2009 Fabrication and characterization of silk fibroin-derived HSA-CCM NPs for cancer therapy Int. J. Nanomedicine. 4 115-22
20. Esmailia M, Ghaffaria S M, Moosavi-Movahedib Z, Atria M S, Sharifizadeha A, Farhadic M, Yousefid R, Choberte J-M, Haertlé T and Moosavi-Movahedi A A 2011 Beta casein-micelle as a nano vehicle for solubility enhancement of CCM; food industry application LWT. Food Sci. Technol. 44 2166-72
21. Loftssona T and Duchêne D 2007 Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 1-11
22. Loftsson T, Magnusdottir A, Masson M and Sigurjonsdottir J F 2002 Self-association and cyclodextrin solubilization of drugs J. Pharm. Sci. 91 2307-16
23. Yallapu M M, Jaggi M and Chauhan S C 2010 Beta-cyclodextrin- CCM self-assembly enhances CCM delivery in prostate cancer cells Colloids Surf. B 79 113-25
24. Kakkar V, Muppu S K, Chopra K and Kaur I P 2013 CCM loaded solid lipid NPs: an efficient formulation approach for cerebral ischemic reperfusion injury in rats Eur. J. Pharm. Biopharm. 85 339-45
25. Yallapu M M, Jaggi M and Chauhan S C 2010 oly(beta-cyclodextrin)/CCM self-assembly: a novel approach to improve CCM delivery and its therapeutic efficacy in prostate cancer cells Macromol. Biosci. 10 1141-51
26. Xia X R, Monteiro-Riviere N A and Riviere J E 2010 An index for characterization of nanomaterials in biological systems Nat. Nanotechnology 5 671-5
27. Pan J, Chan S Y, Lee W G and Kang L 2011 Microfabricated particulate drug-delivery systems Biotechnol. J. 6 1477-87
28. Duncan R 2003 The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2 347-60
29. Ferrari M 2005 Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 161-71
30. Neumann E, Frei E, Funk D, Becker M D, Schrenk H H, Muller-Ladner U and Fiehn C 2010 Native albumin for targeted drug delivery Expert Opin. Drug Deliv. 7 915-25
31. Fiehn C, Neumann E, Wunder A, Krienke S, Gay S and Muller-Ladner U 2004 Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo Ann. Rheum. Dis. 63 884-6
32. Wang S, Gong G, Su H, Liu W, Wang Z and Li L 2014 Self-assembly of plasma protein through disulfide bond breaking and its use as a nanocarrier for lipophilic drugs Polym. Chem. 5 4871-4
33. Zheng J, Du G G, Anderson C T, Keller J P, Orem A, Dallos P and Cheatham M 2006 Analysis of the oligomeric structure of the motor protein prestin J. Biol. Chem. 281 19916-24
34. Gong G, Zhi F, Wang K, Tang X, Yuan A, Zhao L, Ding D and Hu Y 2011 Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting Nanotechnology 22 295603
35. Trynda-Lemiesz L 2004 Paclitaxel-HSA interaction. Binding sites on HAS molecule Bioorg. Med. Chem. 12 3269-75
36. Tian J, Liu J, He W, Hu Z, Yao X and Chen X 2004 Probing the binding of scutellarin to human serum albumin by circular dichroism, fluorescence spectroscopy, FTIR, and molecular modeling method Biomacromolecules 5 1956-61
37. Fink A L 1998 Protein aggregation: folding aggregates, inclusion bodies and amyloid Fold. Des. 3 R9-23
38. Bam N B, Cleland J L, Yang J, Manning M C, Carpenter J F, Kelley R F and Randolph T W 1998 Tween protects recombinant human growth hormone against agitationinduced damage via hydrophobic interactions J. Pharm. Sci. 87 1554-9
39. Avdulov N A, Chochina S V, Daragan V A, Schroeder F, Mayo K H and Wood WG 1996 Direct binding of ethanol to bovine serum albumin: a fluorescent and 13C NMR multiplet relaxation study Biochemistry 35 340-7
40. McQueen-Mason S and Cosgrove D J 1994 Disruption of hydrogen bonding between plant cell wall polymers by proteins that induce wall extension Proc. Natl Acad. Sci. USA 91 6574-8
41. Torchilin V 2011 Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug. Deliv. Rev. 63 131-5